PubMed Health⌕ Search

Biomedical subjects

Claude Andre

Publications and source records attributed to Claude Andre.

5 recordsLinked to original sources

Mite penetration of different types of material claimed as mite proof by the Siriraj chamber method.

BACKGROUND: There are different materials and principles used in the construction of bed encasings. Although these covers claim to have antimite properties, they might not be mite proof. OBJECTIVE: This study evaluated the effectiveness of mite penetration of these covers by using the Siriraj chamber method. METHODS: Thirty-two covers collected from 9 different countries were categorized according to the materials used to manufacture them. They were (1) tightly woven, (2) film or membrane coated and loosely woven, (3) acaricidal coated and loosely woven, (4) nonwoven, (5) film coated and nonwoven, (6) acaricidal coated and nonwoven, and (7) plastic. Adult mites, Dermatophagoides pteronyssinus, were placed on either the outer or inner surfaces of each of the test fabrics for 3 replications, resulting in a total of 6 samples per fabric. All samples were observed for penetration every day for 1 week under a stereomicroscope. If a single mite penetrated any fabric, it was scored as a penetration. RESULTS: Mites penetrated (1) into all samples of film-coated woven and nonwoven covers, an acaricide-coated nonwoven cover, and nonwoven types; (2) from both sides and colonized within the matrix of some samples; and (3) completely in other cases. All of the woven covers and the plastic cover prevented mite penetration. Photomicrographs documented all penetrations. CONCLUSIONS: Tightly woven covers and plastic prevent mite penetration, whereas nonwoven, loosely woven, acaricide-coated, and laminated materials do not. The Siriraj chamber method adequately evaluates the effectiveness of antimite barriers. CLINICAL IMPLICATIONS: For mite avoidance, allergists should recommend the use of tightly woven covers on suspected bedding containing dust mites.

Animals↗

Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.

BACKGROUND: Seasonal allergic rhinitis is common and troublesome. Sublingual immunotherapy (SLIT) has been proposed as an alternative to injection immunotherapy and might offer some advantages if it were effective and practical in a community setting. OBJECTIVES: To assess the efficacy and side-effect profile of SLIT in patients with summer hay fever uncontrolled on current standard medication. To assess the feasibility of delivering SLIT in a United Kingdom general practice setting. METHODS: Double-blind, placebo-controlled study in 186 patients with severe summer hay fever identified from 16 United Kingdom general practices. After a baseline year to ensure balanced groups, subjects were randomized, and SLIT was given for 1 or 2 years and compared with placebo. The principal outcome measure was symptoms as recorded on diary cards. Secondary criteria were skin and conjunctival reactivity, allergen-specific IgE and IgG 4 , and the frequency and severity of adverse effects. RESULTS: One hundred thirty-six subjects completed the study. After 1 year, no significant differences were found between actively treated subjects and the placebo group. After the second year of therapy, subjects who had received 2 years treatment were 6.8 times more likely to show a reduction in nose running (P <.001) and 2.4 times more likely to have reduced sneezing (P <.05) compared with subjects in the placebo group. Benefits for nasal blockage were found at the peak pollen season and were similar in both actively treated groups. CONCLUSION: Sublingual immunotherapy can be given successfully and safely in the community. High-dose SLIT has beneficial effects on nasal symptoms during the peak pollen season in patients with severe seasonal allergic rhinitis. At least 2 years of treatment with SLIT is required to show a benefit.

Administration, Sublingual↗

Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients.

BACKGROUND: Among factors potentially involved in the increased prevalence of allergic diseases, modification of the intestinal bacteria flora or lack of bacterial stimulation during childhood has been proposed. Lactic acid bacteria (LAB) present in fermented foods or belonging to the natural intestinal microflora were shown to exert beneficial effects on human health. Recent reports have indicated their capacity to reduce allergic symptoms. OBJECTIVE: The purpose of this investigation was to determine the effect of LAB on the production of type 2 cytokines, which characterize allergic diseases. METHODS: PBMCs from patients allergic to house dust mite versus those from healthy donors were stimulated for 48 hours with the related Dermatophagoides pteronyssinus allergen or with a staphylococcal superantigen. The effect of LAB preincubation was assessed by measuring the type 2 cytokine production by means of specific ELISA. RESULTS: The tested gram-positive LAB were shown to inhibit the secretion of T(H)2 cytokines (IL-4 and IL-5). This effect was dose dependent and was observed irrespective of the LAB strain used. No significant inhibition was induced by the control, gram-negative Escherichia coli TG1. Interestingly, LAB reduced the T(H)2 cytokine production from allergic PBMCs specifically restimulated with the related allergen. The inhibition mechanism was shown to be dependent on antigen-presenting cells (ie, monocytes) and on the involvement of IL-12 and IFN-gamma. CONCLUSION: The tested LAB strains were demonstrated to exhibit an anti-T(H)2 activity, and thus different strains of this family might be useful in the prevention of allergic diseases.

Allergens↗